Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:03:42.630Z.
Calculation as of: 2026-10-06T21:03:42.630Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1639651ea08d8a43111aa8341d4d68762a5dc33ecadd1da8a92c037613eb041e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$44.72M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.71M
Free Cash Flow Yield
9.49%
TTM Avg
5.71%
3Y Avg
3.18%
5Y Avg
3.18%
Market Cap
$48.76M
Free Cash Flow Yield
N/A
TTM Avg
10.60%
3Y Avg
10.34%
5Y Avg
10.34%
Market Cap
$48.89M
Free Cash Flow Yield
N/A
TTM Avg
3.44%
3Y Avg
3.09%
5Y Avg
2.98%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $46.69M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 9.49% | 5.71% | 3.18% | 3.18% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 10.60% | 10.34% | 10.34% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 3.44% | 3.09% | 2.98% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A | 1.01% | 1.01% | 1.12% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
